SCHEMBL6973280

SCHEMBL6973280

O=C(O)C1(c2ccc(Cl)c(Cl)c2)OCC(c2ccccc2)(c2ccccc2)CO1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 7/20 0.37
SLC6A4 P31645 7/20 0.37
SLC6A3 Q01959 2/20 0.37
CHRNA1 P02708 1/20 0.37
CHRNG P07510 1/20 0.37
CHRNB1 P11230 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37
CHRND Q07001 1/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
CCR2 P41597 3/20 0.36
APP P05067 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
AKR1C3 P42330 1/20 0.36
PSEN1 P49768 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6971603 0.84 CHRNA1 (0.40) SLC6A2SLC6A4SLC6A3CHRNA1CHRNG
SCHEMBL6967893 0.84 CNR1 (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6981777 0.83 AKR1C1 (0.41) CYP2C9MEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL6979503 0.82 OPRM1 (0.48) SLC6A2SLC6A4SLC6A3MAPT
SCHEMBL377756 0.79 MAPK1 (0.40) SLC6A2SLC6A4SLC6A3CHRNA1CHRNG
SCHEMBL6982594 0.78 HSD11B1 (0.39) SLC6A2SLC6A3CHRNA1CHRNGCHRNB1
SCHEMBL6978477 0.78 LMNA (0.39) SLC6A2SLC6A3CHRNA1CHRNGCHRNB1
SCHEMBL6984599 0.76 RXRA (0.53) NPC1RAB9ACYP3A4CYP2C19KDM4E
SCHEMBL6981080 0.74 THRB (0.44) NPC1RAB9AAPPALDH1A1TSHR
SCHEMBL6971207 0.74 OPRM1 (0.44) CHRNA1CHRNGCHRNB1CHRNB2CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed